Literature DB >> 9453076

Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations.

T M Rivera1, A Leone-Bay, D R Paton, H R Leipold, R A Baughman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9453076     DOI： 10.1023/a:1012160703533

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  13 in total

1.  Oral delivery of new heparin derivatives in rats.

Authors:  Y Lee; S H Kim; Y Byun
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.

Authors:  Aaron D Baldwin; Karyn G Robinson; Jaimee L Militar; Christopher D Derby; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-05-21       Impact factor: 4.396

3.  The new heparins.

Authors:  Michael S Conners; Samuel R Money
Journal:  Ochsner J       Date:  2002

Review 4.  New anticoagulant drugs.

Authors:  J I Weitz
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

Review 5.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

6.  Oral delivery of biologically active parathyroid hormone.

Authors:  A Leone-Bay; M Sato; D Paton; A H Hunt; D Sarubbi; M Carozza; J Chou; J McDonough; R A Baughman
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

7.  Oral absorption enhancement of cromolyn sodium through noncovalent complexation.

Authors:  Xuan Ding; Parshuram Rath; Robert Angelo; Thomas Stringfellow; Elizabeth Flanders; Steven Dinh; Isabel Gomez-Orellana; Joseph R Robinson
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 8.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

9.  Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.

Authors:  Constantia E Kast; Davide Guggi; Nina Langoth; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

10.  Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.

Authors:  Shaker A Mousa; Fuming Zhang; Ahmad Aljada; Seema Chaturvedi; Majde Takieddin; Haifeng Zhang; Lianli Chi; M Cristina Castelli; Kristen Friedman; Michael M Goldberg; Robert J Linhardt
Journal:  J Clin Pharmacol       Date:  2007-12       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.